Literature DB >> 3131802

Changes in dopamine autoreceptor sensitivity in an animal model of depression.

R Muscat1, A Towell, P Willner.   

Abstract

Rats exposed for 6 weeks to a variety of mild unpredictable stressors showed reduced consumption of a preferred sucrose solution. The deficit was apparent after 1 week of stress and was maintained for at least 2 weeks after termination of the stress regime. Sucrose preference was unaffected by 2 weeks of treatment with the tricyclic antidepressant DMI but returned to normal after 3 weeks of DMI treatment. Subsensitivity to the anorexic effect of a low dose of apomorphine was seen in vehicle-treated stressed animals, and in unstressed animals following withdrawal from DMI. In both cases, the changes resulted from a failure of apomorphine to reduce eating time (rather than from changes in eating rate); this effect is assumed to represent a subsensitive response to stimulation of dopamine cell body autoreceptors. As the same effect is seen in anhedonic stressed animals and in animals withdrawn from DMI, it is concluded that dopamine autoreceptor desensitization probably does not contribute to clinical improvement following chronic antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131802     DOI: 10.1007/bf00212853

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  Dopamine autoreceptors in the ventral tegmental area show subsensitivity following withdrawal from chronic antidepressant drug treatment.

Authors:  A Towell; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Chronic imipramine administration reduces apomorphine inhibitory effects.

Authors:  C Scavone; M L Aizenstein; R De Lucia; C Da Silva Planeta
Journal:  Eur J Pharmacol       Date:  1986-12-16       Impact factor: 4.432

3.  Apomorphine anorexia: a behavioural and neuropharmacological analysis.

Authors:  P Willner; A Towell; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Apomorphine anorexia: a further pharmacological characterization.

Authors:  R Muscat; P Willner; A Towell
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

Review 5.  The validity of animal models of depression.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat.

Authors:  A Nieoullon; A Cheramy; J Glowinski
Journal:  Brain Res       Date:  1978-06-09       Impact factor: 3.252

Review 7.  Dopamine and depression: a review of recent evidence. I. Empirical studies.

Authors:  P Willner
Journal:  Brain Res       Date:  1983-12       Impact factor: 3.252

Review 8.  Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments.

Authors:  P Willner
Journal:  Brain Res       Date:  1983-12       Impact factor: 3.252

9.  Animal model of depression: pharmacological sensitivity of a hedonic deficit.

Authors:  R J Katz
Journal:  Pharmacol Biochem Behav       Date:  1982-06       Impact factor: 3.533

10.  Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant.

Authors:  P Willner; A Towell; D Sampson; S Sophokleous; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more
  14 in total

1.  Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline.

Authors:  R Muscat; M Papp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Environmental-enrichment-related variations in behavioral, biochemical, and physiologic responses of Sprague-Dawley and Long Evans rats.

Authors:  Anne T M Konkle; Amanda C Kentner; Stephanie L Baker; Angela Stewart; Catherine Bielajew
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-07       Impact factor: 1.232

4.  Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine.

Authors:  S Monleon; P D'Aquila; A Parra; V M Simon; P F Brain; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

5.  Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.

Authors:  M Papp; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

Authors:  P Willner; S Lappas; S Cheeta; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

8.  Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.

Authors:  S Cheeta; C Broekkamp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

9.  Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine.

Authors:  J A Stamford; R Muscat; J J O'Connor; J Patel; S J Trout; W J Wieczorek; Z L Kruk; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression.

Authors:  M Papp; V Klimek; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.